KemPharm Inc

NASDAQ:KMPH  
9.50
+0.66 (+7.47%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)269.58M
Current PEN/A
Forward PE 27.94
2yr Forward PE 24.36
See more stats
Estimates Current Quarter
Revenue$25.06 Million
Adjusted EPS$0.75
See more estimates
10-Day MA$9.27
50-Day MA$9.69
200-Day MA$6.71
See more pivots

KemPharm Inc Stock, NASDAQ:KMPH

1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747
United States of America
Phone: +1.321.939.3416
Number of Employees: 22

Description

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.